Topic: Cancer
Conditions
Interventions
160 participants will be recruited, and randomly allocated on an equal basis to receive either the intervention or usual care or standard care. Participants allocated to the intervention will be refer
Sponsors
University of Leeds
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 16 years or over 2. Diagnosis of advanced incurable disease (locally advanced or metastatic) in one of the following disease areas: 2.1. Breast 2.2. Colon or rectal 2.3. Non-small cell lung cancer 2.4. Prostate 2.5. Upper GI 3. Experiencing cancer related pain (tumour or treatment related) (as assessed by the Clinician) with an average pain score of = 4 on the “average pain” item of the Brief Pain Inventory 4. Has the potential to benefit from palliative care support as assessed by the Clinician 5. An expected prognosis of 12 weeks or more 6. The patient is living at home 7. The patient lives in the local catchment area for a participating hospice 8. The patient is able and willing to provide written informed consent
Exclusion criteria
Exclusion criteria: 1. Previously referred to palliative care team 2. The patient has insufficient literacy, or proficiency in English to contribute to the data collection required for the research 3. Patients will be excluded if they lack capacity to provide informed consent to this trial 4. Patients with dominant chronic pain that is not cancer related (tumour or treatment)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Uptake and retention rate of each intervention recorded throughout the study period 2. Pain severity, measured using the Brief Pain Inventory at 6 and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
England, United Kingdom
Outcome results
None listed